About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System

By: via GlobeNewswire

SAN MATEO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced commercial launch of the FreeClimb® 88 catheter system comprising the FreeClimb 88 catheter and the Tenzing® 8 delivery catheter, all designed to work with the Base Camp® sheath. The FDA 510(k) cleared FreeClimb 88 catheter system offers reliable navigation through tortuous anatomy in the neurovasculature and is available in 125 cm and 132 cm lengths to provide clinicians with the flexibility they need to reach their targeted locations.

“Route 92 Medical continues to advance neurovascular intervention through a suite of solutions designed to work harmoniously to address acute ischemic stroke,” said Tony Chou, CEO of Route 92 Medical. “The FreeClimb 88 access catheter system, powered by Tenzing, addresses the unmet need for effective, super-bore catheters that can reach the M1 segment of the middle cerebral artery consistently. Route 92 Medical is dedicated to giving clinicians new tools to treat their most complex cases.”

The tapered tip of the patented Tenzing 8 delivery catheter significantly reduces ledge effect and allows the FreeClimb 88 catheter to consistently navigate past the ophthalmic artery and predictably reach the M1 segment of the middle cerebral artery (MCA). Tenzing’s soft, tapered tip provides atraumatic tracking in the neurovasculature, and was designed to reach the targeted locations without the use of a microcatheter.

“Having a broader set of tools gives clinicians greater flexibility when treating difficult cases,” said Dr. Ajit Puri, Professor and Director of Neurointervention and Integrated Cerebrovascular Program at University of Massachusetts medical center and Portsmouth Regional Hospital. “The .088" catheter systems will make procedures easier by minimizing set-up complexity, providing vessel size matching leading to distal flow control during the delivery of therapeutic devices, and leveraging the strengths of the Tenzing product design to improve navigation.”

Route 92 Medical’s family of FreeClimb and HiPoint® products simplify endovascular thrombectomy procedures by allowing clinicians to select the optimal length and size of access or aspiration catheter for every case. Route 92 Medical’s FreeClimb and HiPoint products are powered by custom-sized Tenzing delivery catheters, allowing for rapid and predictable delivery to the targeted location. The FreeClimb 88 system joins the company’s growing 88 portfolio, including the Monopoint® system, powered by the HiPoint 88 and Tenzing 8 catheters, and Base Camp sheath.

For more information about other Route 92 Medical-developed neurovascular intervention devices, visit www.route92medical.com/products.

About Route 92 Medical, Inc.

Route 92 Medical is on a mission to improve outcomes for patients undergoing neurovascular intervention through cutting-edge engineering and innovative product design. Founded by physicians, the company collaborates with leading neurovascular clinicians to solve the biggest challenges in neurointervention and deliver meaningful, differentiated solutions that promote clinical success. For more information, visit www.r92m.com or follow the company on LinkedIn.


Contacts:

For media:

Gwen Gordon
Gwen Gordon PR
Gwen@gwengordonpr.com 

Primary Logo

More News

View More
Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
Via MarketBeat
Tickers AMZN
Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
Via MarketBeat
Topics Artificial Intelligence World Trade
Tickers ATRO INOD META
Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Via MarketBeat
Tickers CMG MCD SBUX YUM
Carmakers Step in With Incentives as EV Tax Credit Expires
Via MarketBeat
Topics Economy Government
Tickers F GM TSLA
Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure
Via MarketBeat
Topics Lawsuit
Tickers ZG
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.